EN DE

Dental Patient Care America, Inc (DPAT) Fair Value & Analysis

Healthcare · US · Market cap $1.1M

DP Dental Patient Care America, Inc logo Dental Patient Care America, Inc DPAT · US
Price$0.0419
Fair Value$0.0448
Upside+6.9%
Quality67/100
Watch Dental Patient Care America, Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -66.4% net margin
Low debt · generates free cash flow
Mixed vs. peers (5/11)
Narrow moat 15/100
Evidence: High Range $0.0374 – $0.0925 Share as image

Fair value as of: Jul 29, 2026

From 24 valuation models · updated 12 days ago

Fair value updated Jul 29, 2026, revised from $0.0463 to $0.0448 (−3.3%) since Jun 26, 2026. Share price −5.8% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range ($0.0374 to $0.0925) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$0.3500 $0.0036 Fair Value $0.0448 Aug 2015 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 29, 2026.

How to read this chart

60‑month range $0.0036 – $0.3500 · fair‑value band $0.0374 – $0.0925 · the $0.0419 price screens below the $0.0448 fair value. Dashed = 300-day average. As of Jul 29, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Dental Patient Care America, Inc (DPAT) currently trades at $0.0419, while our model-based Fair Value estimate is $0.0448, implying the stock looks roughly 6.9% fairly valued today. The Quality Score stands at 67/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Dental Patient Care America, Inc generated revenue of $476K at a net margin of -66.4%. Revenue grew 51.6% year over year. Fundamentals as of Jul 29, 2026

Our scenario range runs from $0.0374 (bear case) to $0.0925 (bull case); at $0.0419, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 54% below its 52-week high and 264% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 7%, DPAT screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $0.2900 $0.4700 $0.7700 80
Residual Income $0.1500 $0.2200 $2.44 76
Rev-Margin DCF $0.1600 $0.2600 $0.4500 74
All 24 models by family
DCF Models
FCF DCF $0.3100 $0.4400 $0.8200 38
Owner Earnings $0.2300 $0.4700 $0.9000 31
5Y Revenue Exit $0.1500 $0.2200 $0.3700 39
5Y EBITDA Exit $0.1500 $0.2300 $0.3800 41
5Y P/E Exit $0.3500 $0.8000 $1.40 38
10Y Revenue Exit $0.2000 $0.3600 $0.4200 36
10Y EBITDA Exit $0.2100 $0.3700 $0.6000 37
10Y P/E Exit $0.3400 $0.7300 $1.38 35
Earnings-Based
Graham-Dodd $0.1600 $1.14 $1.60 54
Lynch FV $0.5900 $0.8400 $1.10 50
PEG = 1.0 $0.5900 $0.8400 $1.10 46
EPV $0.0300 $0.0300 $0.0400 59
Multiples
P/E Multiple $0.4000 $0.5300 $0.6600 63
P/S Multiple $0.3100 $0.4100 $0.5100 58
P/B Multiple $0.1800 $0.2400 $0.3000 55
EV/EBIT $0.0900 $0.1200 $0.1500 53
EV/EBITDA $0.0700 $0.1000 $0.1300 54
EV/Revenue $0.0600 $0.0900 $0.1200 43
Asset-Based
NCAV (Graham) $0.0300 $0.0400 $0.0500 50
Growth DCF
Growth DCF $0.2900 $0.4700 $0.7700 80
Rev-Margin DCF $0.1600 $0.2600 $0.4500 74
Economic Profit
Residual Income $0.1500 $0.2200 $2.44 76
ROIC Compounder $0.0300 $0.0300 $0.0400 72
Growth Earnings
Growth-Adj P/E $0.7800 $1.12 $1.45 68

Widest divergence: Growth Earnings ($1.12) versus Economic Profit ($0.0300). Highest evidence: Growth DCF (80).

Notify me when DPAT reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $476K
Revenue growth (YoY) +51.6%
Net margin -66.4%
Free cash flow $660K FY2025
Operating margin -50.4%
EPS (TTM) $-0.0200
More key figures
Net debt $66.5K FY2025

Figures from reported company fundamentals · as of Jul 29, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 74 · Market factors (momentum, volatility) 73

Profitability 92
Margins and returns on capital today
Quality Growth 62
Are margins and returns improving?
Cashflow 81
Earnings quality: real cash, not paper profit
Fin. Strength 63
Balance sheet, leverage, solvency risk
Investment 50
Disciplined investing over empire-building
Low Volatility 40
Calm price path (market factor)
Momentum 96
Price trend over the last 3–12 months (market factor)
52W Momentum 69
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Dental Patient Care America, Inc., through its subsidiaries, provides services to dentists and the dental industry. The company organizes dentists into a co-operative model of contractually networked dental practices, allowing member dentists to access various benefits, such as programs to purchase supplies, laboratory and operating services, insurance and …

Full company description

Dental Patient Care America, Inc., through its subsidiaries, provides services to dentists and the dental industry. The company organizes dentists into a co-operative model of contractually networked dental practices, allowing member dentists to access various benefits, such as programs to purchase supplies, laboratory and operating services, insurance and employee benefits programs, opportunities for profit sharing, preferential business financing, and dental practice transition funding opportunities. It also offers various dental patient marketing programs, such as organization of member dentists into a network, which offers dental care plans to employers and groups. In addition, Dental Patient Care America, Inc. offers dental benefit plans. The company was founded in 1998 and is based in Salt Lake City, Utah.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2007 – FY2025 · reported fiscal years

Dental Patient Care America, Inc reported revenue of $2.9M in FY2025 versus $1.4M in FY2007, a compound +3.9%/yr. Reported net income was $581K in FY2025.

Growth Quality 82/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$2.9M
Latest YoY
+19.1%
Avg. growth/yr (24Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.2%
Revenue +3.9%/yr
FY07 $1.4M
FY08 $476K
FY23 $3.2M
FY24 $2.4M
FY25 $2.9M
Net income
FY07 −$260K
FY08 −$316K
FY23 $9.0K
FY24 $256K
FY25 $581K

Watch DPAT: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Dental Patient Care America, Inc Fair Value". https://www.fairvalue-calculator.com/stock/DPAT

Peer Group

Medical Care Facilities · 261 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 67 · Top 25%
Fair Value upside −5% · Above median
Return on assets -56% · Bottom 25%
Net margin (TTM) -66% · Bottom 25%
Operating margin (TTM) -50% · Bottom 25%
Revenue growth 52% · Top 25%
Debt / equity 0.39× · Higher than median

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/B 0.88× · Cheaper than median
P/S (TTM) 2.36× · Pricier than 75% of peers
P/FCF 1.7× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 27 · sector 23
FUTURE 100 · sector 24
PAST 0 · sector 30
HEALTH 80 · sector 90
DIVIDEND 0 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 29, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare Dental Patient Care America, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Dental Patient Care America, Inc (DPAT) overvalued or undervalued?
As of Jul 29, 2026, our model estimates a fair value of $0.0448 versus a price of $0.0419, about +7% (fairly valued).
What is the fair value of DPAT?
Our model-based fair value for Dental Patient Care America, Inc is $0.0448 (as of Jul 29, 2026), built from audited fundamentals. The current price is $0.0419.
What is the quality score of DPAT?
Dental Patient Care America, Inc has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Dental Patient Care America, Inc (DPAT)?
Dental Patient Care America, Inc reported trailing-twelve-month revenue of about $476K (latest available figure, as of Jul 29, 2026).
What is the net profit margin of DPAT?
The net profit margin of Dental Patient Care America, Inc is about -66.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Dental Patient Care America, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.